News

Viking Therapeutics: Still On Track

Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline. Click here to read more ...

Columbia Emerging Markets Fund Q2 2025 Commentary

Columbia Threadneedle Investments reports 12.86% Q2 gains for its Emerging Markets Fund, led by tech and AI tailwinds. See ...

Blink Charging targets continued sequential revenue growth with $8M annual cost reduction and new product expansion

Explore Blink Charging Co.'s Q2 2025 earnings call insights, highlighting 73% product revenue growth, cost reductions, Zemetric acquisition, and plans ...

Blink Charging Co. (BLNK) Q2 2025 Earnings Call Transcript

Blink Charging Co. ( NASDAQ: BLNK) Q2 2025 Earnings Conference Call August 18, 2025 4:30 PM ET Michael Bercovich - Corporate Participant Michael C. Battaglia - President, CEO & Director Vitalie Stelea ...

Palo Alto Networks, Inc. (PANW) Q4 2025 Earnings Call Transcript

Palo Alto Networks, Inc. ( NASDAQ: PANW) Q4 2025 Earnings Conference Call August 18, 2025 4:30 PM ET Dipak Golechha - Executive VP & CFO Lee Klarich - Executive VP & Chief Product Officer Nikesh Arora ...